Want to see JP:2385 full AI Analyst Report?
2385 Stock Chart & Stats
¥236.00
-¥3.00(-2.38%)
At close: 4:00 PM EST
¥236.00
-¥3.00(-2.38%)
Day’s Range― - ―
52-Week Range¥161.00 - ¥325.00
Previous CloseN/A
Volume39.40K
Average Volume (3M)187.76K
Market Cap
¥5.60B
Enterprise Value¥986.41M
Total Cash (Recent Filing)¥5.26B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)30.4
Beta0.91
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.67%
Share Statistics
EPS (TTM)-8.04
Shares Outstanding26,158,200
10 Day Avg. Volume461,280
30 Day Avg. Volume187,763
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)0.73
Price to Sales (P/S)0.91
P/FCF Ratio8.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA zero-debt capital structure with substantial equity gives durable financial flexibility. It reduces refinancing and interest risks, enables funding of operations, R&D or M&A from internal resources, and provides a buffer to absorb revenue shocks over the coming months.
Rebound In Cash GenerationThe return to positive operating and free cash flow in FY2025 materially improves near-term liquidity and reduces dependence on external funding. Sustained cash generation would allow reinvestment and strategic flexibility, supporting operational recovery over 2–6 months.
Stable Gross MarginsConsistently healthy gross margins indicate resilient product economics and cost structure. Even with top-line pressure, stable gross margins mean the company can restore operating profitability if SG&A is controlled or revenue stabilizes, supporting medium-term recovery.
Bears Say
Multi-year Revenue DeclinePersistent top-line contraction across several years signals structural demand or market-share challenges. Continued revenue decline reduces operating leverage, limits ability to cover fixed costs, and makes margin recovery and sustainable profit generation more difficult.
Recent Profitability LossesMaterial swings from prior profits to consecutive net losses reflect weakening operating performance and cost pressures. Until profitability reverses, negative margins will erode retained earnings and constrain capital allocation despite a strong balance sheet.
Volatile Cash Flow HistoryCash generation has been inconsistent, with FY2023–FY2024 cash burn before the FY2025 rebound. This volatility raises execution risk: a relapse could force cost cuts, asset sales or new financing, undermining strategic initiatives despite recent positive cash flow.
2385 FAQ
What was Soiken Holdings Inc.’s price range in the past 12 months?
Soiken Holdings Inc. lowest stock price was ¥161.00 and its highest was ¥325.00 in the past 12 months.
What is Soiken Holdings Inc.’s market cap?
Soiken Holdings Inc.’s market cap is ¥5.60B.
When is Soiken Holdings Inc.’s upcoming earnings report date?
Soiken Holdings Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 9 days.
How were Soiken Holdings Inc.’s earnings last quarter?
Soiken Holdings Inc. released its earnings results on May 13, 2026. The company reported ¥3.16 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.16.
Is Soiken Holdings Inc. overvalued?
According to Wall Street analysts Soiken Holdings Inc.’s price is currently Overvalued.
Does Soiken Holdings Inc. pay dividends?
Soiken Holdings Inc. pays a Annually dividend of ¥10 which represents an annual dividend yield of 4.67%. See more information on Soiken Holdings Inc. dividends here
What is Soiken Holdings Inc.’s EPS estimate?
Soiken Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Soiken Holdings Inc. have?
Soiken Holdings Inc. has 26,158,200 shares outstanding.
What happened to Soiken Holdings Inc.’s price movement after its last earnings report?
Soiken Holdings Inc. reported an EPS of ¥3.16 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.394%.
Which hedge fund is a major shareholder of Soiken Holdings Inc.?
Currently, no hedge funds are holding shares in JP:2385
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Soiken Holdings Inc.
Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and commercialization of cosmetics and nutritional supplements, alongside the licensing and continued development of biomarker technologies. Soiken also conducts market research and post-market surveillance specifically for dietary supplements. A key area of its work includes the research, development, and sale of functional materials like lactoferrin, as well as pharmaceuticals derived from ascochlorin. Furthermore, Soiken applies its biomarker expertise to perform clinical evaluations for food products. The company extends its services to provide vital support for physician-initiated pharmaceutical clinical research, comprehensive health screenings, and personalized health guidance. It also partners with health insurance societies to offer contracted health guidance, facilitate specialized health check-ups for dependents of the insured, and implement programs designed for diabetes prevention.
Technical Analysis
Linical Co., Ltd.
―
Trans Genic Inc.
―
MEDINET Co., Ltd.
―
TMS Co., Ltd.
―
PRISM BioLab Co. LTD
―